Global Cerebral Embolic Protection Devices for TAVI 麻豆原创 Research Report 2025

Publication ID:

PB503257263

Publication Date:

March 27, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Cerebral Embolic Protection Devices for TAVI was valued at US$ 79.8 million in the year 2024 and is projected to reach a revised size of US$ 392 million by 2031, growing at a CAGR of 25.9% during the forecast period.
Transcatheter aortic valve implantation (TAVI), also known as TAVR or Transcatheter aortic valve replacement is used in the treatment of aortic stenosis (AS). Transcatheter aortic valve implantation is the therapy of choice for patients with severe aortic stenosis who have prohibitive or high surgical risk. However, the benefit of TAVI is attenuated by the occurrence of major disabling stroke which is associated with increased mortality and early-reduced quality of life. Despite advances in TAVI technology, stroke remains a serious complication that is associated with significant negative outcomes. The majority of these occur in the acute phase following TAVI where cerebral embolic events are frequent. Cerebral embolic protection devices (CEPD) have been developed to minimize the risk of peri-procedural ischemic stroke during TAVI.
Venus Medtech (Keystone Heart) is the largest manufacturer of cerebral embolic protection devices for TAVI in the world, has a share of over 90%. Geographically speaking, cerebral embolic protection devices for TAVI currently have a market only in Europe and North America, with North America accounting for about 55% of the share. In terms of artery coverage cover, non-total artery coverage segment holds an important share of over 90%. In terms of application, hospital segment accounts for about 80% of the global share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cerebral Embolic Protection Devices for TAVI, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cerebral Embolic Protection Devices for TAVI.
The Cerebral Embolic Protection Devices for TAVI market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cerebral Embolic Protection Devices for TAVI market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cerebral Embolic Protection Devices for TAVI manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Boston Scientific (Claret Medical)
Venus Medtech (Keystone Heart)
Transverse Medical
Innovative Cardiovascular Solutions
Protembis GmbH
Filterlex Medical
Emboline
Segment by Type
Total Artery Coverage
Non-total Artery Coverage
Segment by Application
Hopsital
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cerebral Embolic Protection Devices for TAVI manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cerebral Embolic Protection Devices for TAVI in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Cerebral Embolic Protection Devices for TAVI 麻豆原创 Overview
1.1 Product Definition
1.2 Cerebral Embolic Protection Devices for TAVI by Type
1.2.1 Global Cerebral Embolic Protection Devices for TAVI 麻豆原创 Value Comparison by Type (2024 VS 2031)
1.2.2 Total Artery Coverage
1.2.3 Non-total Artery Coverage
1.3 Cerebral Embolic Protection Devices for TAVI by Application
1.3.1 Global Cerebral Embolic Protection Devices for TAVI 麻豆原创 Value by Application (2024 VS 2031)
1.3.2 Hopsital
1.3.3 Others
1.4 Global Cerebral Embolic Protection Devices for TAVI 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Cerebral Embolic Protection Devices for TAVI Revenue 2020-2031
1.4.2 Global Cerebral Embolic Protection Devices for TAVI Sales 2020-2031
1.4.3 Global Cerebral Embolic Protection Devices for TAVI 麻豆原创 Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cerebral Embolic Protection Devices for TAVI 麻豆原创 Competition by Manufacturers
2.1 Global Cerebral Embolic Protection Devices for TAVI Sales 麻豆原创 Share by Manufacturers (2020-2025)
2.2 Global Cerebral Embolic Protection Devices for TAVI Revenue 麻豆原创 Share by Manufacturers (2020-2025)
2.3 Global Cerebral Embolic Protection Devices for TAVI Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cerebral Embolic Protection Devices for TAVI, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cerebral Embolic Protection Devices for TAVI, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cerebral Embolic Protection Devices for TAVI, Product Type & Application
2.7 Global Key Manufacturers of Cerebral Embolic Protection Devices for TAVI, Date of Enter into This Industry
2.8 Global Cerebral Embolic Protection Devices for TAVI 麻豆原创 Competitive Situation and Trends
2.8.1 Global Cerebral Embolic Protection Devices for TAVI 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Cerebral Embolic Protection Devices for TAVI Players 麻豆原创 Share by Revenue
2.8.3 Global Cerebral Embolic Protection Devices for TAVI 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cerebral Embolic Protection Devices for TAVI 麻豆原创 Scenario by Region
3.1 Global Cerebral Embolic Protection Devices for TAVI 麻豆原创 Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cerebral Embolic Protection Devices for TAVI Sales by Region: 2020-2031
3.2.1 Global Cerebral Embolic Protection Devices for TAVI Sales by Region: 2020-2025
3.2.2 Global Cerebral Embolic Protection Devices for TAVI Sales by Region: 2026-2031
3.3 Global Cerebral Embolic Protection Devices for TAVI Revenue by Region: 2020-2031
3.3.1 Global Cerebral Embolic Protection Devices for TAVI Revenue by Region: 2020-2025
3.3.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Region: 2026-2031
3.4 North America Cerebral Embolic Protection Devices for TAVI 麻豆原创 Facts & Figures by Country
3.4.1 North America Cerebral Embolic Protection Devices for TAVI 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cerebral Embolic Protection Devices for TAVI Sales by Country (2020-2031)
3.4.3 North America Cerebral Embolic Protection Devices for TAVI Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cerebral Embolic Protection Devices for TAVI 麻豆原创 Facts & Figures by Country
3.5.1 Europe Cerebral Embolic Protection Devices for TAVI 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cerebral Embolic Protection Devices for TAVI Sales by Country (2020-2031)
3.5.3 Europe Cerebral Embolic Protection Devices for TAVI Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cerebral Embolic Protection Devices for TAVI 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Cerebral Embolic Protection Devices for TAVI 麻豆原创 Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cerebral Embolic Protection Devices for TAVI Sales by Region (2020-2031)
3.6.3 Asia Pacific Cerebral Embolic Protection Devices for TAVI Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cerebral Embolic Protection Devices for TAVI 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Cerebral Embolic Protection Devices for TAVI 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cerebral Embolic Protection Devices for TAVI Sales by Country (2020-2031)
3.7.3 Latin America Cerebral Embolic Protection Devices for TAVI Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cerebral Embolic Protection Devices for TAVI 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Cerebral Embolic Protection Devices for TAVI 麻豆原创 Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cerebral Embolic Protection Devices for TAVI Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cerebral Embolic Protection Devices for TAVI Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cerebral Embolic Protection Devices for TAVI Sales by Type (2020-2031)
4.1.1 Global Cerebral Embolic Protection Devices for TAVI Sales by Type (2020-2025)
4.1.2 Global Cerebral Embolic Protection Devices for TAVI Sales by Type (2026-2031)
4.1.3 Global Cerebral Embolic Protection Devices for TAVI Sales 麻豆原创 Share by Type (2020-2031)
4.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Type (2020-2031)
4.2.1 Global Cerebral Embolic Protection Devices for TAVI Revenue by Type (2020-2025)
4.2.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Type (2026-2031)
4.2.3 Global Cerebral Embolic Protection Devices for TAVI Revenue 麻豆原创 Share by Type (2020-2031)
4.3 Global Cerebral Embolic Protection Devices for TAVI Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cerebral Embolic Protection Devices for TAVI Sales by Application (2020-2031)
5.1.1 Global Cerebral Embolic Protection Devices for TAVI Sales by Application (2020-2025)
5.1.2 Global Cerebral Embolic Protection Devices for TAVI Sales by Application (2026-2031)
5.1.3 Global Cerebral Embolic Protection Devices for TAVI Sales 麻豆原创 Share by Application (2020-2031)
5.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Application (2020-2031)
5.2.1 Global Cerebral Embolic Protection Devices for TAVI Revenue by Application (2020-2025)
5.2.2 Global Cerebral Embolic Protection Devices for TAVI Revenue by Application (2026-2031)
5.2.3 Global Cerebral Embolic Protection Devices for TAVI Revenue 麻豆原创 Share by Application (2020-2031)
5.3 Global Cerebral Embolic Protection Devices for TAVI Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boston Scientific (Claret Medical)
6.1.1 Boston Scientific (Claret Medical) Company Information
6.1.2 Boston Scientific (Claret Medical) Description and Business Overview
6.1.3 Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boston Scientific (Claret Medical) Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.1.5 Boston Scientific (Claret Medical) Recent Developments/Updates
6.2 Venus Medtech (Keystone Heart)
6.2.1 Venus Medtech (Keystone Heart) Company Information
6.2.2 Venus Medtech (Keystone Heart) Description and Business Overview
6.2.3 Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Venus Medtech (Keystone Heart) Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.2.5 Venus Medtech (Keystone Heart) Recent Developments/Updates
6.3 Transverse Medical
6.3.1 Transverse Medical Company Information
6.3.2 Transverse Medical Description and Business Overview
6.3.3 Transverse Medical Cerebral Embolic Protection Devices for TAVI Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Transverse Medical Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.3.5 Transverse Medical Recent Developments/Updates
6.4 Innovative Cardiovascular Solutions
6.4.1 Innovative Cardiovascular Solutions Company Information
6.4.2 Innovative Cardiovascular Solutions Description and Business Overview
6.4.3 Innovative Cardiovascular Solutions Cerebral Embolic Protection Devices for TAVI Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Innovative Cardiovascular Solutions Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.4.5 Innovative Cardiovascular Solutions Recent Developments/Updates
6.5 Protembis GmbH
6.5.1 Protembis GmbH Company Information
6.5.2 Protembis GmbH Description and Business Overview
6.5.3 Protembis GmbH Cerebral Embolic Protection Devices for TAVI Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Protembis GmbH Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.5.5 Protembis GmbH Recent Developments/Updates
6.6 Filterlex Medical
6.6.1 Filterlex Medical Company Information
6.6.2 Filterlex Medical Description and Business Overview
6.6.3 Filterlex Medical Cerebral Embolic Protection Devices for TAVI Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Filterlex Medical Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.6.5 Filterlex Medical Recent Developments/Updates
6.7 Emboline
6.7.1 Emboline Company Information
6.7.2 Emboline Description and Business Overview
6.7.3 Emboline Cerebral Embolic Protection Devices for TAVI Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Emboline Cerebral Embolic Protection Devices for TAVI Product Portfolio
6.7.5 Emboline Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cerebral Embolic Protection Devices for TAVI Industry Chain Analysis
7.2 Cerebral Embolic Protection Devices for TAVI Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cerebral Embolic Protection Devices for TAVI Production Mode & Process Analysis
7.4 Cerebral Embolic Protection Devices for TAVI Sales and 麻豆原创ing
7.4.1 Cerebral Embolic Protection Devices for TAVI Sales Channels
7.4.2 Cerebral Embolic Protection Devices for TAVI Distributors
7.5 Cerebral Embolic Protection Devices for TAVI Customer Analysis
8 Cerebral Embolic Protection Devices for TAVI 麻豆原创 Dynamics
8.1 Cerebral Embolic Protection Devices for TAVI Industry Trends
8.2 Cerebral Embolic Protection Devices for TAVI 麻豆原创 Drivers
8.3 Cerebral Embolic Protection Devices for TAVI 麻豆原创 Challenges
8.4 Cerebral Embolic Protection Devices for TAVI 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Boston Scientific (Claret Medical)
Venus Medtech (Keystone Heart)
Transverse Medical
Innovative Cardiovascular Solutions
Protembis GmbH
Filterlex Medical
Emboline

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.